account_id none on file
legal_name Actinium Pharmaceuticals, Inc.
ticker ATNM
cik 1388320
domain actiniumpharma.com
linkedin_company_url https://www.linkedin.com/company/actinium-pharmaceuticals-inc-
entry_point_account_id none on file
name Actinium Pharmaceuticals Inc.
exchange NYSE
sector Health Care
hq New York, NY, United States
sector index/company/sector/health-care/
calls 0 filings 10 executives 2 family 0
why_nownone on file
callsnone on file
filings
The Company entered into a lease for corporate office space effective June 1, 2022. The lease has a term of five years and two months , with an expiration date of July 30, 2027 and current annual rent of $ 0.6 million.
filing / Aug 7, 2026 / receipt
enroll in trials, or the inability of patients to comply with clinical trial protocols if quarantines or travel restrictions are implemented
filing / Aug 7, 2026 / receipt
Restricted cash relates to a certificate of deposit held as collateral for a letter of credit issued in connection with the Company’s lease of corporate office space.
filing / Aug 7, 2026 / receipt
The implementation of cost containment measures or other healthcare reforms may prevent us from being able to generate revenue, attain profitability, or commercialize our product candidates.
filing / Aug 7, 2026 / receipt
A significant trend in the United States healthcare industry and elsewhere is cost containment. Government authorities and third-party
filing / Aug 7, 2026 / receipt
Company has an operating lease for corporate office space, an operating lease for manufacturing space and a finance lease for office equipment
filing / May 8, 2026 / receipt
Company entered into a lease for corporate office space effective June 1, 2022. The lease has a term of five years and two months , with
filing / May 8, 2026 / receipt
payor or policy actions, which may include cost containment and healthcare reform measures. Such policy actions could have a material
filing / May 8, 2026 / receipt
The implementation of cost containment measures or other healthcare reforms may prevent us from being able to generate revenue, attain profitability, or commercialize our product candidates.
filing / May 8, 2026 / receipt
Customer service | {"ats": "smartrecruiters", "city": null, "state": null, "job_id": "743999662967686", "remote": false, "category": "other", "function": "other", "location": "Newyork, Newyork, United
company_statement / Nov 25, 2017 / receipt
executives
| Richard I. Steinhart | Director | - | receipt |
| Sandesh Seth | Chief Executive Officer | - | receipt |
familynone on file
upcoming
| 2026-11-13 | earnings call | scheduled | ir |
changes
| 2017-06-09 | Chief Executive Officer, appointed | sec_8k |
| 2013-11-12 | Director, appointed | sec_8k |
| 2013-05-31 | director, departed | sec_8k |
| 2013-02-28 | Chief Executive Officer, departed | sec_8k |
mcp_package_hint
slug actinium-pharmaceuticals-inc
listing_url https://steadybase.io/company/data/index.json
mcp_url https://mcp.steadybase.io/mcp
steadybase-$